CAG vs MZTI: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: CAG is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CAG and MZTI share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CAG and MZTI exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Conagra Brands is one of the largest packaged-food companies in North America, with a portfolio spanning frozen meals (Healthy Choice, Marie Callender's, Banquet, Birds Eye), snacks (Slim Jim, Angie's Boomchickapop, Duke's) and grocery staples (Hunt's, Chef Boyardee, Reddi-wip, Orville Redenbacher's). The company sells primarily through US grocery, mass and club retailers, and it has leaned its strategy toward higher-growth frozen and snacking categories while managing legacy shelf-stable brands.

Full CAG guide

The Marzetti Company makes and markets specialty foods through two segments. Retail sells branded products into grocery, mass and club stores: Marzetti dressings, dips and caramel, New York Bakery frozen garlic bread, Sister Schubert's dinner rolls, Reames frozen noodles, Cardini's and Girard's dressings, plus a large licensed portfolio that puts restaurant names on shelf products, including Olive Garden dressings, Chick-fil-A sauces and dressings, Buffalo Wild Wings sauces, Texas Roadhouse steak sauces and Subway sauces. Foodservice manufactures dressings, sauces and baked goods for national chain restaurant accounts and distributors, a lower-margin but steadier business tied to menu volumes rather than grocery shelf turns. The company is headquartered in the Columbus, Ohio area, employs roughly ~3,700 people, and runs a June fiscal year end.

Full MZTI guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CAG drivers: Frozen and snacks as the growth engine; Margin recovery and cost management.
• MZTI drivers: Licensed restaurant brands on the grocery shelf; Bachan's and the sauce adjacency.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The biggest risk is prolonged volume softness in packaged food as consumers trade down to private label or shift spending, which would keep pressure on sales and margins. For MZTI, retail volume is the central risk: pounds shipped fell about ~5.6% in the fiscal third quarter, and a business priced for durability does not usually get credit for cost savings alone.

Pick CAG if you believe its drivers more; MZTI if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CAG and MZTI guides.

CAG. Conagra trades at a low earnings multiple relative to its history, reflecting weak sales growth and concern over the sustainability of its dividend. Fiscal 2025 net sales declined year over year and fiscal 2026 guidance points to roughly flat organic sales with lower adjusted EPS. The unusually high yield is the market's way of pricing in the risk that the payout may need to be reset.

MZTI. Fiscal 2025 revenue was about ~$1.91 billion with net income near ~$167 million, and the trailing twelve months through the March 2026 quarter run slightly ahead of that at roughly ~$1.94 billion and ~$175 million. Fiscal third quarter 2026, reported May 4, 2026, showed consolidated net sales of about ~$453.4 million (down ~1.0%), retail down ~3.2% to roughly ~$233.8 million, foodservice up ~1.5% to about ~$219.6 million, and diluted EPS of ~$1.35 versus ~$1.49 a year earlier. Shares fell about ~6.6% that day to close near ~$116. Fiscal fourth quarter and full-year results, covering the June 2026 quarter and the first partial contribution from Bachan's, are due in late August 2026 and had not been reported at the time of writing.

Headline figures (approximate, JULY 2026): CAG shows revenue (fy2025) ~$11.6B, adjusted eps (fy2025) ~$2.30, adjusted eps guidance (fy2026) ~$1.70 to $1.85, dividend (annual) ~$1.40 per share; MZTI shows revenue (ttm) ~$1.94B, net income (ttm) ~$175M, eps (ttm, diluted) ~$6.39, market cap ~$3.13B.

CAG and MZTI are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CAG and MZTI exposure against your real portfolio. It is not an investment adviser.